Adjunctive Wet Cupping for Acute Non-Specific Low Back Pain

Summary

This prospective randomized controlled trial evaluated the effectiveness and safety of adjunctive wet cupping therapy combined with standard pharmacological treatment in adults presenting to the emergency department with acute non-specific low back pain. A total of 80 adult patients were randomly assigned to receive either wet cupping therapy plus intravenous dexketoprofen or intravenous dexketoprofen alone. Pain intensity was assessed using the Visual Analogue Scale (VAS) at baseline and at 10, 20, and 30 minutes after treatment, as well as at 24 hours. Secondary outcomes included the need for rescue analgesia, analgesic consumption during the first 24 hours after discharge, patient satisfaction, and treatment-related adverse events. The study was designed to determine whether adding wet cupping therapy to standard pharmacological treatment provides additional pain relief and improves short-term clinical outcomes in patients with acute non-specific low back pain.

Timeline

Start

2022-03-07

Primary completion

2022-06-17

Completion

2022-06-17

Drugs

Indications

No indication recorded.